BD BBL SENSI-DISC RIFAMPICINAS
Mexico·Clase I·III. DIAGNOSTIC AGENTS·BECTON DICKINSON DE MÉXICO, S.A. DE C.V.·Registered April 03, 2018PARA PRUEBAS SEMICUANTITATIVAS DE SUSCEPTIBILIDAD IN VITRO DE MICROORGANISMOS GRAM NEGATIVOS Y/O GRAM POSITIVOS
FOR SEMI-QUANTITATIVE IN VITRO SUSCEPTIBILITY TESTING OF GRAM-NEGATIVE AND/OR GRAM-POSITIVE MICROORGANISMS
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- SENSIDISCOS DE RIFAMPICINAS
- Trade Name (English)
- RIFAMPICIN SENSIDISCOS
- Analysis ID
- 868R2018 SSA
- Registration Date
- April 03, 2018
- Name (Spanish)
- BECTON DICKINSON DE MÉXICO, S.A. DE C.V.
- Name (English)
- BECTON DICKINSON DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for BD BBL SENSI-DISC RIFAMPICINAS (BD BBL SENSI-DISC RIFAMPICINAS) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 868R2018 SSA and manufactured by BECTON DICKINSON DE MÉXICO, S.A. DE C.V.. The device was registered on April 03, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.